AT352297B - Verfahren zur herstellung von neuen, biologisch aktiven lysergsaeureamiden - Google Patents
Verfahren zur herstellung von neuen, biologisch aktiven lysergsaeureamidenInfo
- Publication number
- AT352297B AT352297B AT286376A AT286376A AT352297B AT 352297 B AT352297 B AT 352297B AT 286376 A AT286376 A AT 286376A AT 286376 A AT286376 A AT 286376A AT 352297 B AT352297 B AT 352297B
- Authority
- AT
- Austria
- Prior art keywords
- biologically active
- acid amides
- producing new
- lysergic acid
- new biologically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU75GO00001309A HU172649B (hu) | 1975-04-24 | 1975-04-24 | Sposob poluchenija novykh biologicheski aktivnykh lizergamidov |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA286376A ATA286376A (de) | 1979-02-15 |
| AT352297B true AT352297B (de) | 1979-09-10 |
Family
ID=10996791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT286376A AT352297B (de) | 1975-04-24 | 1976-04-20 | Verfahren zur herstellung von neuen, biologisch aktiven lysergsaeureamiden |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4101552A (de) |
| JP (1) | JPS5940833B2 (de) |
| AT (1) | AT352297B (de) |
| AU (1) | AU503465B2 (de) |
| BE (1) | BE841049A (de) |
| BG (1) | BG33885A3 (de) |
| CA (1) | CA1081215A (de) |
| CH (1) | CH619708A5 (de) |
| CS (1) | CS194758B2 (de) |
| DD (1) | DD125487A5 (de) |
| DE (1) | DE2617738A1 (de) |
| DK (1) | DK144127C (de) |
| FR (1) | FR2308366A1 (de) |
| GB (1) | GB1512874A (de) |
| HU (1) | HU172649B (de) |
| IL (1) | IL49447A (de) |
| NL (1) | NL7604266A (de) |
| PL (1) | PL102509B1 (de) |
| SE (1) | SE425783B (de) |
| SU (1) | SU604493A3 (de) |
| YU (1) | YU42144B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2802023A1 (de) * | 1977-01-28 | 1978-08-03 | Sandoz Ag | Neue ergotderivate, ihre herstellung und verwendung |
| GB1584464A (en) * | 1977-04-19 | 1981-02-11 | Farmaceutici Italia | Ergot alkaloids |
| IT1192260B (it) * | 1977-07-05 | 1988-03-31 | Simes | Derivati di ergoline-2-tioeteri e loro solfossidi |
| AU553809B2 (en) * | 1981-07-21 | 1986-07-31 | Farmitalia Carlo Erba S.P.A. | Ergoline derivatives |
| CH653333A5 (de) * | 1981-11-04 | 1985-12-31 | Sandoz Ag | N-substituierte ergolin- und 9,10-didehydroergolinderivate, ihre herstellung und sie enthaltende arzneimittel. |
| YU254782A (en) * | 1981-12-18 | 1986-10-31 | Schering Ag | Process for making new ergot anilides |
| DE3362248D1 (en) * | 1982-04-13 | 1986-04-03 | Erba Farmitalia | Ergoline derivatives, process for producing the ergoline derivatives and pharmaceutical compositions containing them |
| GB2173189B (en) * | 1985-02-21 | 1988-04-27 | Maruko Pharmaceutical Co | Ergoline derivatives and salts thereof and pharmaceutical compositions thereof |
| US4910206A (en) * | 1986-07-14 | 1990-03-20 | Sandoz Pharmaceuticals Corp. | 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists |
| US4902691A (en) * | 1988-12-19 | 1990-02-20 | Eli Lilly And Company | Heteroalkylamides of (8-β)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT2 receptors |
| BR112017015487A2 (pt) * | 2015-01-20 | 2018-01-30 | Xoc Pharmaceuticals Inc | Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo |
| WO2018223065A1 (en) | 2017-06-01 | 2018-12-06 | Xoc Pharmaceuticals, Inc. | Ergoline derivatives for use in medicine |
| KR20230024378A (ko) | 2020-06-12 | 2023-02-20 | 벡클리 싸이테크 리미티드 | 5-메톡시-n, n-디메틸트립타민의 벤조에이트 염을 포함하는 조성물 |
| GB202212116D0 (en) | 2022-08-19 | 2022-10-05 | Beckley Psytech Ltd | Pharmaceutically acceptable salts and Compositions thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2090430A (en) * | 1937-08-17 | Lysergic acid amides and process for | ||
| US2736728A (en) * | 1954-12-06 | 1956-02-28 | Lilly Co Eli | Preparation of lysergic acid amides |
| DE1040560B (de) * | 1955-11-21 | 1958-10-09 | Lilly Co Eli | Verfahren zur Herstellung von Lysergsaeureamiden |
| US2997470A (en) * | 1956-03-05 | 1961-08-22 | Lilly Co Eli | Lysergic acid amides |
| GB1112909A (en) * | 1964-09-15 | 1968-05-08 | Sandoz Ltd | Ergoline derivatives |
| CH496010A (de) * | 1967-04-20 | 1970-09-15 | Richter Gedeon Vegyeszet | Verfahren zur Herstellung von d-Lysergsäureamiden |
| SE396753B (sv) * | 1970-05-18 | 1977-10-03 | Richter Gedeon Vegyeszet | Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien |
| IL41409A (en) * | 1972-02-04 | 1977-04-29 | Richter Gedeon Vegyeszet | Lysergic acid amides and process for their preparation |
| HU169073B (de) * | 1974-05-28 | 1976-09-28 |
-
1975
- 1975-04-24 HU HU75GO00001309A patent/HU172649B/hu not_active IP Right Cessation
-
1976
- 1976-04-20 CH CH491176A patent/CH619708A5/de not_active IP Right Cessation
- 1976-04-20 IL IL49447A patent/IL49447A/xx unknown
- 1976-04-20 AT AT286376A patent/AT352297B/de not_active IP Right Cessation
- 1976-04-22 NL NL7604266A patent/NL7604266A/xx not_active Application Discontinuation
- 1976-04-23 AU AU13283/76A patent/AU503465B2/en not_active Expired
- 1976-04-23 FR FR7612014A patent/FR2308366A1/fr active Granted
- 1976-04-23 CA CA250,887A patent/CA1081215A/en not_active Expired
- 1976-04-23 BE BE166395A patent/BE841049A/xx not_active IP Right Cessation
- 1976-04-23 BG BG033012A patent/BG33885A3/xx unknown
- 1976-04-23 DD DD192492A patent/DD125487A5/xx unknown
- 1976-04-23 DK DK184176A patent/DK144127C/da not_active IP Right Cessation
- 1976-04-23 DE DE19762617738 patent/DE2617738A1/de active Granted
- 1976-04-23 SE SE7604724A patent/SE425783B/xx not_active IP Right Cessation
- 1976-04-23 SU SU762349104A patent/SU604493A3/ru active
- 1976-04-23 CS CS762697A patent/CS194758B2/cs unknown
- 1976-04-23 GB GB16533/76A patent/GB1512874A/en not_active Expired
- 1976-04-23 US US05/679,866 patent/US4101552A/en not_active Expired - Lifetime
- 1976-04-23 YU YU1031/76A patent/YU42144B/xx unknown
- 1976-04-23 PL PL1976189001A patent/PL102509B1/pl unknown
- 1976-04-24 JP JP51046135A patent/JPS5940833B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK184176A (da) | 1976-10-25 |
| GB1512874A (en) | 1978-06-01 |
| FR2308366A1 (fr) | 1976-11-19 |
| SE425783B (sv) | 1982-11-08 |
| CA1081215A (en) | 1980-07-08 |
| CS194758B2 (en) | 1979-12-31 |
| DE2617738A1 (de) | 1976-11-18 |
| SU604493A3 (ru) | 1978-04-25 |
| PL102509B1 (pl) | 1979-04-30 |
| IL49447A (en) | 1979-11-30 |
| SE7604724L (sv) | 1976-10-25 |
| JPS51131898A (en) | 1976-11-16 |
| JPS5940833B2 (ja) | 1984-10-03 |
| YU42144B (en) | 1988-06-30 |
| ATA286376A (de) | 1979-02-15 |
| BE841049A (fr) | 1976-10-25 |
| DK144127B (da) | 1981-12-14 |
| BG33885A3 (en) | 1983-05-16 |
| US4101552A (en) | 1978-07-18 |
| DE2617738C2 (de) | 1989-10-19 |
| DD125487A5 (de) | 1977-04-20 |
| AU1328376A (en) | 1977-10-27 |
| HU172649B (hu) | 1978-11-28 |
| NL7604266A (nl) | 1976-10-26 |
| CH619708A5 (de) | 1980-10-15 |
| FR2308366B1 (de) | 1978-12-08 |
| YU103176A (en) | 1982-08-31 |
| IL49447A0 (en) | 1976-06-30 |
| AU503465B2 (en) | 1979-09-06 |
| DK144127C (da) | 1982-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT351164B (de) | Verfahren zur herstellung von neuen cephalos- porinderivaten | |
| AT360663B (de) | Verfahren zur herstellung von neuen 6,7- -benzomorphanen | |
| AT342075B (de) | Verfahren zur herstellung von neuen silicium-zinn-verbindungen | |
| AT352297B (de) | Verfahren zur herstellung von neuen, biologisch aktiven lysergsaeureamiden | |
| AT356671B (de) | Verfahren zur herstellung von neuen n,n'-thio- -di-carbamaten | |
| AT347463B (de) | Verfahren zur herstellung von neuen 1,1,1- triarylalkylaminen und deren saeureadditions- salzen | |
| AT354434B (de) | Verfahren zur herstellung von neuen 1,4- diphenyl-3-pyrazolin-5-onen | |
| ATA145077A (de) | Verfahren zur herstellung von neuen ergolen- -derivaten | |
| ATA454376A (de) | Verfahren zur herstellung von neuen 2,6-dinitro-3-azido-4-trifluormethylanilinen und -hydrazinen | |
| AT359658B (de) | Verfahren zur herstellung von neuen cyclischen amiden | |
| AT354650B (de) | Verfahren zur herstellung von neuen bicyclo- heptenderivaten | |
| ATA519676A (de) | Verfahren zur herstellung von neuen behensaureestern, deren isomeren und saureadditionssalzen | |
| ATA328376A (de) | Verfahren zur herstellung von neuen 3-aminomethyl-2-phenylbicyclo(2,2,2)octanen und deren saureadditionssalzen | |
| AT352298B (de) | Verfahren zur herstellung von neuen vincan- derivaten | |
| ATA438776A (de) | Verfahren zur herstellung von neuen 16-athern von fusidinsaurederivaten | |
| AT342565B (de) | Verfahren zur herstellung von neuen 3,4-dichlorphenon-o-(2-aminoathyl)-oximathern und deren saureadditionssalzen | |
| DD129214A5 (de) | Verfahren zur herstellung von neuen 1,9-dihydroxy-hexahydrodibenzopyranen | |
| AT353957B (de) | Verfahren zur herstellung von neuen cephalos- porinderivaten | |
| ATA418276A (de) | Verfahren zur herstellung von neuen, substituierten 1,2,4-oxadiazolidin-3-on-verbindungen | |
| AT344725B (de) | Verfahren zur herstellung von neuen bis-isothiuronium-salzen | |
| AT349630B (de) | Verfahren zur herstellung von neuen antibiotika | |
| ATA504978A (de) | Verfahren zur herstellung von neuen thienothiazinderivaten | |
| ATA516875A (de) | Verfahren zur herstellung von neuen imidazolderivaten | |
| ATA504878A (de) | Verfahren zur herstellung von neuen thienothiazinderivaten | |
| ATA505178A (de) | Verfahren zur herstellung von neuen thieno- thiazinderivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee | ||
| ELJ | Ceased due to non-payment of the annual fee |